Glycyrrhizic Acid-Based Carbonized Dots Boost Antiviral Activity Against Influenza A Virus Via Multisite Inhibition Mechanisms

Chengfei Li,Pengfei Han,Haiying Mao,Changjie Lv,Kun Huang,Meilin Jin
DOI: https://doi.org/10.1021/acsami.2c21319
IF: 9.5
2023-01-01
ACS Applied Materials & Interfaces
Abstract:Influenza A virus (IVA) has been continuously causing pandemics in several animal hosts and has become a worldwide public health threat. Currently, antiviral drugs have become associated with a lot of side effects and limited activity against emerging drug-resistant influenza viruses. Therefore, the development of novel antiviral drugs is of great importance. In this study, we synthesized a kind of carbon dots (CDs) with high dispersibility from glycyrrhizic acid (GA) using a simple dry heating method. Compared with glycyrrhizic acid alone, GA-CDs exhibit superior solubility and significantly improve the antiviral property against IVA. Investigation of the mechanism revealed that GA-CDs act against IVA mainly by inhibiting viral internalization, replication of the viral genome, neuraminidase activity, and host inflammatory responses. More importantly, in a mouse model, GA-CDs can significantly alleviate the clinical symptoms and decrease mortality and lung viral titers. In vitro and in vivo experiments demonstrate that GA-CDs possess extraordinary therapeutic effects; therefore, we propose that GA-CDs may be a promising alternative therapy for IVA infection.
What problem does this paper attempt to address?